137 results on '"Capoferri, Adam A."'
Search Results
2. Combined HIV-1 sequence and integration site analysis informs viral dynamics and allows reconstruction of replicating viral ancestors
3. A quantitative approach for measuring the reservoir of latent HIV-1 proviruses
4. Low genetic diversity may be an Achilles heel of SARS-CoV-2
5. Haemopoietic cell transplantation in patients living with HIV
6. Allogeneic bone marrow transplantation with post-transplant cyclophosphamide for patients with HIV and haematological malignancies: a feasibility study
7. Defective proviruses rapidly accumulate during acute HIV-1 infection
8. Brief Report: Rebound HIV Viremia With Meningoencephalitis After Antiretroviral Therapy Interruption After Allogeneic Bone Marrow Transplant
9. Phylogenetic inference for the study of within-host HIV-1 dynamics and persistence on antiretroviral therapy
10. HIV Expression in Infected T Cell Clones.
11. Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane
12. Reduced Frequency of Cells Latently Infected With Replication-Competent Human Immunodeficiency Virus-1 in Virally Suppressed Individuals Living in Rakai, Uganda
13. Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regimen
14. PP 7.7 – 00055 Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to a Dolutegravir-based antiretroviral regiment
15. Rapamycin-mediated mTOR inhibition uncouples HIV-1 latency reversal from cytokine-associated toxicity
16. Quantitation of the latent HIV-1 reservoir from the sequence diversity in viral outgrowth assays
17. A Pre-Vaccination Baseline of SARS-CoV-2 Genetic Surveillance and Diversity in the United States
18. Short Communication: Persistence of HIV After Allogeneic Bone Marrow Transplant in a Dually Infected Individual
19. A primary CD4+ T cell model of HIV-1 latency established after activation through the T cell receptor and subsequent return to quiescence
20. Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4+ T Cells Permissive for Latent HIV-1 Infection
21. 2020 SARS-CoV-2 diversification in the United States: Establishing a pre-vaccination baseline
22. Assessment of West Nile Virus Lineage 2 Dynamics in Greece and Future Implications
23. Hematopoietic Cell Transplantation in HIV patients
24. Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)
25. Reduced HIV-1 latent reservoir outgrowth and distinct immune correlates among women in Rakai, Uganda
26. A Randomized Trial of EPOCH-Based Chemotherapy with Vorinostat for Highly Aggressive HIV-Associated Lymphomas: Updated Results Evaluating Impact of Diagnosis-to-Treatment Interval (DTI) and Pre-Protocol Systemic Therapy on Outcomes
27. HIV Infected T Cells Can Proliferate in vivo Without Inducing Expression of the Integrated Provirus
28. MOESM3 of Quantitation of the latent HIV-1 reservoir from the sequence diversity in viral outgrowth assays
29. Antiretroviral Adherence, Elevated Viral Load, and Drug Resistance Mutations in Human Immunodeficiency Virus–infected Women Initiating Treatment in Pregnancy: A Nested Case-control Study
30. Comparison of Immune Responses to Different Versions of VLP Associated Stabilized RSV Pre-Fusion F Protein
31. Antiretroviral Adherence, Elevated Viral Load, and Drug Resistance Mutations in Human Immunodeficiency Virus–infected Women Initiating Treatment in Pregnancy: A Nested Case-control Study.
32. Cross-reactive microbial peptides can modulate HIV-specific CD8+ T cell responses
33. THE FRACTION OF CELLS WITH UNSPLICED HIV RNA IS NOT ASSOCIATED WITH PLASMA VIREMIA.
34. 28 Optimised ART and alloBMT to reduce HIV reservoirs
35. Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape
36. Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics
37. Diverse fates of uracilated HIV-1 DNA during infection of myeloid lineage cells
38. Author response: Diverse fates of uracilated HIV-1 DNA during infection of myeloid lineage cells
39. Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane.
40. Cross-reactive microbial peptides can modulate HIV-specific CD8+ T cell responses.
41. EARLY EVOLUTION OF HIV-1 FROM TRANSMITTED FOUNDERS DURING ACUTE INFECTION.
42. Safety of Optimized Antiretroviral Therapy During Allogeneic Matched and Haploidentical Bone Marrow Transplant in HIV+ Individuals
43. A primary CD4+ T cell model of HIV-1 latency established after activation through the T cell receptor and subsequent return to quiescence.
44. A primary CD4+T cell model of HIV-1 latency established after activation through the T cell receptor and subsequent return to quiescence
45. MOESM1 of Quantitation of the latent HIV-1 reservoir from the sequence diversity in viral outgrowth assays
46. MOESM4 of Quantitation of the latent HIV-1 reservoir from the sequence diversity in viral outgrowth assays
47. MOESM1 of Quantitation of the latent HIV-1 reservoir from the sequence diversity in viral outgrowth assays
48. Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regimen.
49. Brief Report: Rebound HIV Viremia With Meningoencephalitis After Antiretroviral Therapy Interruption After Allogeneic Bone Marrow Transplant.
50. 2020 SARS-CoV-2 diversification in the United States: Establishing a pre-vaccination baseline.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.